Morsua, Jaime M.

HRN: 14-74-01  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/06/2023
CEFTAZIDIME 1GM (VIAL)
12/06/2023
12/12/2023
IV
1g
Q8
Pleural Effusion Right Prob Sec To Parapneumonic Process
Checking Final Appropriateness 
12/13/2023
CEFIXIME 200MG (CAP)
12/13/2023
12/19/2023
ORAL
200mg
BID
Pleural Effusion Right Prob Sec To Parapneumonic Process
Checking Final Appropriateness 
01/05/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/05/2024
01/11/2024
IVT
1.5g
Q8
CAP MR; Pleural Effusion R
Checking Final Appropriateness 
01/09/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/09/2024
01/15/2024
IV
1.5g
Q8
CAP-MR; Pleural Effusion
Checking Final Appropriateness 
01/13/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/13/2024
01/19/2024
IVT
4.5g
Q8
CAP MR; Loculated Pneumohydrothorax R
Rejected 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: